ESSEX BIO-TECH (01061) announced that on January 15, 2026, its wholly-owned subsidiary, Majeton Pte Ltd (Majeton), entered into an exclusive distribution agreement with Osteopore International Pte Ltd (Osteopore). Osteopore is a global leader in the field of 3D-printed, bionic, and bio-absorbable implants. Under the distribution agreement, Osteopore has appointed Majeton as its exclusive distributor for innovative dental, orthodontic, and maxillofacial products in Mainland China, Hong Kong, and Macau. The anticipated contract value of the distribution agreement exceeds RMB 12 million, which includes upfront and milestone payments, with the potential for further additional revenue generated through product procurement and supply. This collaboration with Osteopore marks a significant milestone for the Group in the oral care market, expanding its portfolio of dental, orthodontic, and maxillofacial solutions, and will collectively support the Group's pursuit of sustainable growth in the Chinese market.